Trump administration reclassifies cannabis as less dangerous

The Trump administration reclassified cannabis from Schedule I to Schedule III under the Controlled Substances Act, signaling a shift in federal drug policy. This change, led by the U.S. Drug Enforcement Administration (DEA), aims to facilitate medical research and reduce legal barriers for cannabis-related businesses.